Showing results (31-40 of 77) with videos related to
Sort By:
Pageof 8
BMJ (Clinical Research Ed.)|November 12, 2013
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysisSripal Bangalore, Bora Toklu, Nicholas Amoroso, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2010
Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic RegistrySripal Bangalore, Helen A Vlachos, Faith Selzer, et al.Circulation|December 30, 2004
Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary interventionRuchira Glaser, Faith Selzer, David P Faxon, et al.Ultrasound in Medicine & Biology|June 21, 2019
Localized Blood-Brain Barrier Opening in Ovine Model Using Image-Guided Transcranial Focused UltrasoundKyungho Yoon, Wonhye Lee, Emily Chen, et al.Circulation|September 6, 2006
A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing GroupHarlan M Krumholz, Peter M Currie, Barbara Riegel, et al.The American Journal of Cardiology|October 18, 2011
Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry)Kevin R Bainey, Faith Selzer, Howard A Cohen, et al.Journal of the American College of Cardiology|February 16, 2013
Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trialGilles R Dagenais, Jiang Lu, David P Faxon, et al.Circulation. Cardiovascular Interventions|October 20, 2011
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summaryDavid P Faxon, John W Eikelboom, Peter B Berger, et al.Circulation|March 30, 2011
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart diseaseGilles R Dagenais, Jiang Lu, David P Faxon, et al.Thrombosis and Haemostasis|July 26, 2011
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspectiveDavid P Faxon, John W Eikelboom, Peter B Berger, et al.Pageof 8